| Identifier | Protein names | Gene names | Cross reference refseq | Length | Species |
| A0A024R5T9 | Glucosaminyl (N-acetyl) transferase 3, mucin type, isoform CRA_a; | GCNT3; | NULL | 438 | human |
| A0A024R7I7 | RAB3A, member RAS oncogene family, isoform CRA_a; | RAB3A; | NULL | 220 | human |
| A0A024R4G1 | Leucine rich repeat containing 47, isoform CRA_a; | LRRC47; | NULL | 583 | human |
| A0A024QZ99 | Uncharacterized protein; | MGC3020; | NULL | 147 | human |
| Q9H9J1 | HCG1782272; cDNA FLJ12704 fis, clone NT2RP1000836; | NULL | NULL | 124 | human |
| A0A024QZU0 | Receptor (TNFRSF)-interacting serine-threonine kinase 1, isoform CRA_a; | RIPK1; | NULL | 671 | human |
| A0A024R3T3 | Transmembrane protein 63A, isoform CRA_a; | TMEM63A; | NULL | 807 | human |
| A0A024RC51 | SCAN domain containing 2, isoform CRA_a; | SCAND2; | NULL | 306 | human |
| B9EGC0 | Interleukin 4 receptor; | IL4R; | NULL | 825 | human |
| A0A024R5I6 | Leucine rich repeat and fibronectin type III domain containing 4, isoform CRA_a; | LRFN4; | NULL | 635 | human |
| A0A024RBB7 | Nucleosome assembly protein 1-like 1, isoform CRA_a; | NAP1L1; | NULL | 391 | human |
| A0A024R0F1 | Transcription termination factor, RNA polymerase II, isoform CRA_a; | TTF2; | NULL | 1162 | human |
| A0A024R813 | Eyes absent homolog 1 (Drosophila), isoform CRA_g; | EYA1; | NULL | 592 | human |
| A0A024R912 | Uridine-cytidine kinase; EC 2.7.1.48; | UCK2; | NULL | 261 | human |
| A0A024R7E0 | BTB (POZ) domain containing 14B, isoform CRA_a; | BTBD14B; | NULL | 527 | human |
| Q0IJ44 | FGFR3 protein; Fragment; | FGFR3; | NP_000133.1;NP_001156685.1;NP_075254.1; | 480 | human |
| A0A024RB48 | Tensin like C1 domain containing phosphatase (Tensin 2), isoform CRA_a; | TENC1; | NULL | 1285 | human |
| A0A024RBC0 | KIT ligand, isoform CRA_a; | KITLG; | NULL | 273 | human |
| A0A024RDV9 | Spastic paraplegia 20, spartin (Troyer syndrome), isoform CRA_a; | SPG20; | NULL | 666 | human |
| A0A024RAZ8 | Single-strand-selective monofunctional uracil-DNA glycosylase 1, isoform CRA_a; | SMUG1; | NULL | 270 | human |
UrgentMab™: Thinking is cheap. Test your ideas, fast and furious. |
 |
|
Custom monoclonal antibody in one month. As low as $200-300 per antigen. |
|
A product of Absolution |
|
SEAL™: Today's out-of-reach protein targets made accessible. |
|
|
Same budget, 5-10 times more antibodying SEAL your protein. Successes too. |
|
A product of Absolution |
|
PETAL™: Fast and high throughput antibody discover platform. |
 |
|
Deliver customized antibody in two weeks at price of category antibody Proteome-scale antibody discovery for any organism or proteome Biomarker discovery for biological processes or human diseases |
|
A product of Absolution |
|
AbFocus™: Target all the modification sites of your protein, affordably. |
|
|
Test them with a panel of AbFocus antibodies It is so affordable that you can focus on testing, not guessing |
|
A product of Absolution |
Mabome™: Catch the antibody gold rush.? Lead the next omics revolution. |
|
|
First-ever antibody proteomics technology. High quality monoclonal antibodies for your favorite proteome. As low as $19/monoclonal antibody |
|
A product of Absolution |
AbTarget™: Performing antibody for your proteome.? Guaranteed |
|
|
Fast, efficient monoclonal antibody development for proteins in a proteome Pay for successful antibodies only |
|
A product of Absolution |
AbProfile™: Discover an array of unbiased differences.? Proteome-scale |
|
|
50,000 monoclonal antibodies on an array.100 times more content. Differential profiling thousands of cell surface receptorsand plasma proteins |
|
A product of Absolution |
|
SMAL™:?All big things have a SMAL beginning. |
|
|
High success rate for mAb generation Deliver a panel of high affinity mAbs Flexible and optional fee structure for minimizing risks |
|
A product of Absolution |
AbX™: X=anything.? Find your antibody within |
|
|
currently 7species.?200,000 mAbs.70,000 proteins 3 new organisms are being AbXed/day Pre-made anti-peptide mAbs against all proteins in nature. |
|
A product of AbStore |
AbStop™: The last stop of antibody development. The most successful stop. |
|
|
Pre-designed antibody packages against high value targets The most aggressive and comprehensive protein targeting Best for diagnostics and therapeutic antibody development |
|
A product of AbStore |